Analysts Set Phreesia, Inc. (NYSE:PHR) PT at $29.42

Phreesia, Inc. (NYSE:PHR) has been given a consensus recommendation of “Moderate Buy” by the twelve ratings firms that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $29.42.

Several brokerages have weighed in on PHR. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $23.00 price target on shares of Phreesia in a report on Thursday, September 5th. Canaccord Genuity Group restated a “buy” rating and set a $34.00 target price on shares of Phreesia in a research note on Thursday, September 5th. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research note on Thursday, September 5th. Truist Financial raised their price target on Phreesia from $29.00 to $31.00 and gave the company a “buy” rating in a report on Friday, September 6th. Finally, JPMorgan Chase & Co. upped their price objective on Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Monday, September 9th.

Insider Buying and Selling at Phreesia

In related news, CFO Balaji Gandhi sold 3,502 shares of the business’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $23.25, for a total value of $81,421.50. Following the sale, the chief financial officer now owns 98,578 shares in the company, valued at $2,291,938.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Chaim Indig sold 2,644 shares of the firm’s stock in a transaction that occurred on Tuesday, July 16th. The stock was sold at an average price of $23.74, for a total value of $62,768.56. Following the completion of the sale, the chief executive officer now directly owns 1,219,361 shares of the company’s stock, valued at approximately $28,947,630.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Balaji Gandhi sold 3,502 shares of Phreesia stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $81,421.50. Following the completion of the transaction, the chief financial officer now owns 98,578 shares of the company’s stock, valued at approximately $2,291,938.50. The disclosure for this sale can be found here. Insiders sold 46,364 shares of company stock worth $1,132,627 in the last quarter. 5.80% of the stock is owned by corporate insiders.

Institutional Trading of Phreesia

A number of institutional investors have recently bought and sold shares of the stock. Capital International Investors increased its position in Phreesia by 221.1% during the first quarter. Capital International Investors now owns 2,593,063 shares of the company’s stock valued at $62,052,000 after acquiring an additional 1,785,463 shares during the last quarter. Champlain Investment Partners LLC purchased a new position in shares of Phreesia during the 1st quarter worth about $29,941,000. Brown Advisory Inc. grew its holdings in Phreesia by 22.2% during the 4th quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock valued at $91,451,000 after purchasing an additional 716,374 shares during the last quarter. Norges Bank purchased a new stake in Phreesia in the 4th quarter worth about $8,199,000. Finally, Blair William & Co. IL lifted its stake in Phreesia by 42.6% in the first quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock worth $18,012,000 after purchasing an additional 224,950 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors.

Phreesia Stock Up 3.9 %

PHR stock opened at $24.69 on Friday. The business’s 50-day moving average price is $23.72 and its 200-day moving average price is $22.71. The stock has a market cap of $1.42 billion, a P/E ratio of -11.38 and a beta of 0.93. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03. Phreesia has a twelve month low of $12.05 and a twelve month high of $29.16.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.